Judge Profile

Eric C. Jeschke

127 IP cases indexed. Covers patent matters.

Cases Presided Over

127 cases indexed | Page 5 of 5

patent denied

Imperative Care, Inc. v.Inari Medical, Inc. et al.

· IPR2025-00728

The PTAB denied Imperative Care's petition to institute an IPR against Inari Medical's embolism‑treatment patent, finding no reasonable likelihood of unpatentability. The petition relied on anticipation and obviousness over Garrison and other references, but lacked sufficient particularity.

patent instituted

Imperative Care, Inc. v.Inari Medical, Inc. et al.

· IPR2025-00728

The PTAB granted Imperative Care’s petition to institute inter partes review of Inari Medical’s hemostasis‑valve patent, finding a reasonable likelihood of unpatentability for claims 1‑9.

patent all challenged claims unpatentable

Imperative Care, Inc. v.Inari Medical, Inc. et al.

· IPR2025-00728

The PTAB held that all nine claims of Inari Medical’s hemostasis‑valve patent are unpatentable, finding anticipation by Schaffer and obviousness over combinations with Hartley, Eller and Garrison. The decision hinges on the Board’s construction that the claimed filament must be flexible, which the prior art does not disclose.

patent terminated or settled

SIG Sauer Inc. v.True Velocity, Inc.

· IPR2025-00861

SIG SAUER and True Velocity settled their IPR dispute over patent 8,561,543, leading the Board to dismiss the proceeding before trial.

patent instituted

Imperative Care, Inc. v.Inari Medical, Inc. et al.

· IPR2025-01021

The PTAB instituted an inter partes review of Inari Medical’s 11,554,005 patent covering a vacuum aspiration system with hemostasis valve. Petitioner Imperative Care showed a reasonable likelihood of prevailing on at least one claim, especially claim 1, based on obviousness over Garrison, Schaffer and other references.

patent instituted

Imperative Care, Inc. v.Inari Medical, Inc. et al.

· IPR2025-01021

The PTAB instituted an inter partes review of Inari Medical’s 11,697,011 hemostasis valve patent after Imperative Care demonstrated a reasonable likelihood of unpatentability on claims 1‑9.

patent instituted

Imperative Care, Inc. v.Inari Medical, Inc. et al.

· IPR2025-01021

Imperative Care secured institution of an IPR against Inari Medical’s hemostasis‑valve patent, covering claims 1‑9, on grounds of anticipation and obviousness.

1 •••345
Arctic Invent — IP Strategy

Facing a similar IP matter?

Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.

Consult our team →